6533b85ffe1ef96bd12c116a

RESEARCH PRODUCT

Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey.

S MercadanteF RoilaO BerrettoR LabiancaS CasiliniG BotteroV TrovaS CascinuF Di VitoV LorussoG TroccoliL EndrizziB DanieleA MartoniG MariniS VitelloS RomitoG SbalzariniG SerravezzaP ManenteS MolicaS PalazzoT PranteraM MerlanoG Di GirolamoD AmadoriA SobreroR AlgeriS BrettiE GrecoM D'aprileC ForcignanoA BonettiE AitiniE PiazzaL PivaD TabbiadonG Carteni'G CatalanoO AlabisoG LandriscinaL DogliottiG FilippelliG CatalanoR Berte'S RicciL ManzioneC IaconoM. MarangoloNicolo' GebbiaSergio Palmeri

subject

AdultMalemedicine.medical_specialtySettore MED/06 - Oncologia MedicaCross-sectional studyPain medicineMEDLINEPainSeverity of Illness IndexNeoplasmsOncology Service HospitalEpidemiologySeverity of illnessmedicinePrevalenceHumansAgedAged 80 and overPrimary Health Carebusiness.industryCancer painEpidemiologyOpioidsNursing researchPhysicians FamilyMiddle AgedLarge sampleAnalgesics OpioidCross-Sectional StudiesOncologyItalyFamily medicineHealth Care SurveysPhysical therapyFemaleCancer painbusiness

description

The aim of this national cross-sectional survey was to draw information on pain prevalence and intensity from a large sample of patients who were admitted to oncologic centres for different reasons and to evaluate the pain treatment and possible influencing factors.A total of 2,655 patients completed the study. Nine hundred and one patients (34%) reported pain.Higher pain levels were observed in inpatients, in the presence of bone metastases, and with low levels of Eastern Cooperative Oncology Group status. The number of patients receiving strong opioids increased with the highest levels of pain. However, a significant part of patients with moderate-severe pain were not receiving appropriate medication, patients being predominantly administered non-opioid drugs. General practitioners' attitudes did not negatively influence the opioid prescription.The results of this survey indicate a need for continuing educational and informative program in pain management for oncologists and more generally for any physician dealing with cancer patients.

10.1007/s00520-008-0456-7https://pubmed.ncbi.nlm.nih.gov/18478276